6 drug(s) with this reaction
3,111 total reports
Seizure has been reported as an adverse reaction across 6 drug(s) manufactured by Abbvie Inc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 3,111 adverse event reports mention seizure in connection with Abbvie Inc products.
This page provides a breakdown of which Abbvie Inc drugs are most commonly associated with seizure, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
The following Abbvie Inc drugs have seizure listed in their FDA adverse event reports, sorted by report count:
In addition to seizure, the following adverse reactions have been reported across Abbvie Inc's drug portfolio:
6 drug(s) manufactured by Abbvie Inc have seizure listed in their FDA adverse event reports: DIVALPROEX SODIUM, RISANKIZUMAB-RZAA, ATOGEPANT, PARICALCITOL, SEVOFLURANE, and others.
There are a combined 3,111 reports of seizure across 6 Abbvie Inc drug(s) in the FDA adverse event database.